Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

NCT01340898 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

753

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infection

Interventions

BIOLOGICAL: Meningococcal vaccine GSK 134612
BIOLOGICAL: SynflorixTM
BIOLOGICAL: Infanrix-IPV/HiberixTM

Sponsor

GlaxoSmithKline